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The aim of this study was to assess the efficacy of fissurectomy with skin advancement flap in
healing chronic anal fissures without hypertonia of the internal anal sphincter. Twenty-six con-
secutive patients who failed healing after well-practiced topical medical therapy were enrolled.
Anorectal manometry was performed preoperative and 6 months postoperatively. All patients
were treated with fissurectomy and advancement flap through healthy skin tissue. All patients
healed completely within 30 days from operation. The intensity and the duration of pain post-
defecation was reduced significantly with respect to the preoperative values starting from the first
defecation. One patient suffered urinary retention, two patients suffered infections, and two
partial breakdownswere recorded. At 6 months themaximum resting pressure values were similar
to those were detected preoperatively. One month after surgery, anal incontinence was reported in
seven patients, four of whom complained about it preoperatively. At 12 months, only three sub-
jects reported incontinence. No patients needed reoperation and no recurrences were detected.
The fissurectomy, in combination with advancement flap, is a safe sphincter-saving procedure for
the treatment of chronic anal fissures without hypertonia of internal anal sphincter that fails
medical conservative treatment.
T HE PATHOPHYSIOLOGY IN the development of chronicanal fissures (CAF) is thought to be a combination
of trauma to the anal mucosa, internal anal sphincter
(IAS) hypertonia, and poor vascularization.1 Most
current medical and surgical therapies aim to reduce
the maximum resting pressure (MRP) of IAS to in-
crease the mucosal blood flow and promote healing.
First line treatment is increasingly pharmacological.
The drugs are thought to be less expensive, simpler,
easily available with a good compliance, and are as-
sociated with fewer complications, requiring no hos-
pitalization. The most frequently used drugs are nitric
oxide donors, calcium channel blockers, and neuro-
toxins. After chemical sphincterotomy, healing rates of
CAF range from 30 to 96 per cent whereas transitory
minor incontinence for flatus and soiling has been
reported in up to 12 per cent of patients.2 The treatment
of CAF that fails medical therapy still remains unclear.
Surgical treatment is generally recommended and lat-
eral sphincterotomy seems to be the operation of
choice after the failure of the conservative treatment
resulting in success rates as high as 96 to 100 per cent.3
As indicated by Nelson4 in a recent systematic review
of randomized surgical trials, after sphincterotomy the
overall risk of incontinence is about 10 per cent,
mostly to flatus without any specification of the du-
ration of this problem (transitory or permanent).
However, it is a common belief that the risk of per-
manent incontinence is about 1 per cent. Nonetheless,
this does not take into account the normal weakening
of the sphincter with age and the possibility of future
anorectal surgery, radiation, or obstetrical trauma.
Therefore, the risk of incontinence after lateral internal
sphincterotomy should be considered looking at the
life span of the patient especially a young, otherwise
healthy person.5 There is evidence that anal fissures do
not always associate with hypertonic IAS; in fact CAF
associated with normal or hypotonic IAS has been
reported both in the elderly6 and in the postpartum
period.7 Moreover, recently, manometric studies docu-
mented that an elevated number of patients with CAF
have a normal MRP.8–11 The absence of hypertonic IAS
is observed more frequently in female patients12 and in
the anterior CAF.11 The patients with resistant CAF
without hypertonia of IAS benefit more from the
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sphincter sparing procedure than from lateral internal
sphincterotomy, which may lead to incontinence.
The present study was designed to assess the effi-
cacy of fissurectomy with advancement flap through
healthy skin in healing the CAF unresponsive to
medical therapy without hypertonia of IAS.
Methods
Twenty-six consecutive patients affected by CAF
without hypertonia of IAS unresponsive to medical
therapy and refused further medical treatment were
enrolled in this prospective study from January 2002 to
June 2007. All subjects gave written informed consent
and the local ethics committee approved the study.
Exclusion criteria were the presence of multiple and
lateral fissures, chronic fistulas-in-ano, syphilis, in-
flammatory bowel disease, anal abscess, or malignant
disease. CAF resistant to medical treatment were de-
fined as those that fail healing after well-practiced
topical medical therapy and high fiber dietary sup-
plementation. Preoperative anorectal manometry was
performed at least 4 weeks after cessation of glyceril
trinitrate ointment or calcium channel blocker therapy
or 15 weeks after toxin botulinum injection. A mano-
metric control was repeated 6 months after surgery.
The manometry was carried out by a manometric
sensor with 2.1 mm external diameter with four circle
orifices and with a latex microballoon at its extremity
(Marquat C87, Boissy, St-Leger, France). The machine
was connected to a polygraph (Narco, Byo-System
MMS 200, Houston, TX) using the station pull-
through method with perfusion of normal saline; the
patient was lying in the right lateral position. On the
manometry, MRP was defined as maximum pressure
detected on resting. Data collected by our anorectal
pathophysiology laboratory, according to others,9
showed that normal range MRP values were from 45 to
85 mm Hg. CAF without hypertonia has been defined
as having MRP values less than 85 mm Hg.9 All pa-
tients underwent fissurectomy in the gynecological
position under spinal anesthesia. An Eisenhammer
anal speculum was gently inserted into the anal canal,
taking care to avoid sphincter dilation. After injection of
5 mL of local anesthetic solution, constitute of 100 mg
cloridrate mepivacain, and 0.025 mg L-adrenaline, the
fibrotic edges were excised with a scalpel until a nor-
mal nonfibrotic anodermal tissue showed sufficient
bleeding. The sentinel skin tag and hypertrophied
papilla at the level of dentate line, when were present,
were excised. The granulation tissue at the base of the
fissure was curetted until there were clean muscle fi-
bers of the IAS. There was no use of diathermy and
careful attention was given not to damage the IAS.
Standard advancement anoplasty was performed using
a flap of healthy skin tissue, which was mobilized and
then advanced with its blood supply to fill the defect.
The flap was secured without tension to the anal canal
and the skin was closed tension free in a V-Y manner
behind the advanced flap. All procedures were carried
out by the same senior surgeon (GD). Before surgery,
all patients received a small volume of phosphate-saline
enema. Metronidazole was administered intravenous in
a dose of 500 mg 1 hour before surgery. Subsequently, it
was administered per os at the dosage of 250 mg for 7
days three times daily. During the first 2 weeks after the
operation, patients took variable doses of psyllium fiber.
A laxative preparation (sennosides) was given orally to
subjects who had not yet passed stools 3 days after sur-
gery. Enema, suppositories, and all rectal manipulations
were avoided. Immediately after surgery, all patients
received 100 mg of diclofenac intramuscular for anal-
gesia andwere instructed to take only 100mgnimesulide
tablets as requested. The primary end point was fissure
healing and MRP changes of the anal sphincter; the
secondary end point included symptoms relief (bleeding,
pain, pruritus) and the immediate and long-time com-
plications (incontinence, anal stenosis, keyhole de-
formity, and urinary retention) that were recorded on pro
forma. The fissure healing was defined as a complete
epithelialization of the advancement flap. Both duration
and intensity of pain postdefecationwere evaluated. Pain
intensity was scored with a visual analogical scale from
0 to 10, where 0 corresponded to no pain and 10 to the
worse pain conceivable.13 Anal incontinence was as-
sessed 1, 6, and 12 months after the surgical operation
using the Pescatori grading system: A, incontinence for
flatus andmucus; B, liquid stool; C, solid stool; and 1 for
occasional, 2 for weekly, and 3 for daily.14 Patients were
discharged 24 to 48 hours after surgery; afterwards they
were examined in ambulatory until theywere completely
healed and theywere also checked at 1, 6, and 12months
after the surgical operation. Independently of these
scheduled appointments patients were seen on request.
Statistical Analysis
Continuous variables were expressed as mean with
standard deviation and qualitative data as absolute
frequencies; MRP values were also given as median
and range. Student’s t test with Welch correction was
used to analyze the differences of pain score and pain
duration at each registration point. Values of P < 0.05
were considered statistically significant.
Results
Baseline Characteristics of Patients
The patients included were 23 female and 3 male
with a median age of 37 years (range 18–56). Bowel
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habitus was normal in six patients, constipation was
detected in 19 subjects, and diarrhea in one patient in
accordance with up-dated Rome diagnostic criteria
previously published.15 Seven females were nullipare,
whereas nine had given birth vaginally one time or
more and seven had cesarean delivery. Preoperatively,
four patients reported anal incontinence. Among them,
according to the Pescatori grading system, three pa-
tients were classified as A2 and one as A3.
Fissure Characteristics
The mean duration of symptoms was 19.5 ± 9.3
months. Six patients failed a therapeutic course of
glycerin trinitrate alone. Eight patients had previously
failed only botulinum toxin therapy at the dosage of
40 UI. Among the remaining 12 patients, six, after
failure of glycerin trinitrate, were treated with injection
of 40 UI botulinum toxin into the anal sphincter and
four patients had a topically calcium channel blocker
paste. The clinical characteristics of CAF are reported
in Table 1. Preoperatively, the MRP values were 62.3 ±
15.6 mm Hg (mean ± standard deviation) with a me-
dian of 65 mm Hg and a range of 36 to 82 mm Hg.
Healing Fissure and Relief of Symptoms
All patients healed completely within 30 days from
operation. The intensity and the duration of pain
postdefecation was reduced significantly with respect
to the preoperative values starting from the first defe-
cation (P < 0.0001 and P < 0.0001, respectively) (Fig.
1A,B). None of the patients complained of pain,
bleeding, or pruritus 30 days after surgery. Analgesics
consumption decreased significantly after the first
defecation (data not shown).
MRP and Anal Continence
Preoperatively, theMRP values were a median of 60.3
mm Hg with a range of 36 to 82. At 6 months revision,
MRP values were a median of 56.8 mm Hg with a range
of 41 to 80. Comparing the values among them, no
significant difference was recorded. Preoperatively, four
patients reported anal incontinence. Among them,
according to the Pescatori grading system, three subjects
were classified as A2 and one as A3. One month after
surgery, anal incontinencewas reported in sevenpatients.
Two patients were classified as A1, three as A2, and two
as A3. At 6 months, four patients had incontinence, two
of whom were classified as A1 and two as A2. At 12
months, only three patients had incontinence (Table 2).
Complications and Follow-up
One patient suffered urinary retention. There were
no cases of anal stenosis or keyhole deformity. No
necrosis of the transposed flap were observed. Only
TABLE 1. Clinical Characteristics
N %
Hypertrophied anal papillae 21 80.8
Skin tags 18 69.2
Site of fissure
Posterior midline 10 38.5





FIG. 1. (A) Intensity of pain, evaluated with visual analogue
scale (VAS), given preoperatively (Pre) and at the moment of
defecations. Significant differences versus preoperative values
* P < 0.0001. (B) Duration of pain, given in minutes, measured
preoperatively (Pre) and at the moment of defecations. Significant
differences versus preoperative values * P < 0.0001.
TABLE 2. Anal Incontinence Assessed Before and After 1 and 6
Months from Operation According to Pescatori Grading System
Preoperative 1 Month 6 Months 12 Months
1 A2 A1 — —
2 A2 A2 A1 —
3 A2 A3 A2 A2
4 A3 A3 A2 A2
5 — A1 — —
6 — A2 A1 A1
7 — A2 — —
THE AMERICAN SURGEON February 2010208 Vol. 76
complications of slight entity have been observed; in
particular, two infections and a partial break down
occurred in two cases. At 12 months of follow-up, no
recurrences were recorded and in no cases were sur-
gical reintervention necessary.
Discussion
This study showed that fissurectomy in combination
with advancement flap associated with the excision of
the sentinel skin tag and hypertrophied papilla when
presents, is a safe sphincter-saving procedure for the
treatment of CAF resistant to conservative treatment
without hypertonia of IAS. In recent years, there has
been increased recognition that some patients with
CAF may have normal or low resting pressure (Table
3). The ability of surgeons to identify the patients with
normotonic or hypotonic IAS by simple digital rectal
examination is poor.9 Routine manometry of all pa-
tients with CAF may, at present, be unachievable be-
cause of the lack of both expertise and resources in
every hospital.9 If manometry is used on a selective
basis, it should be reserved to the patients failing
topical therapy.9 Topical treatment for CAF is
designed to relieve IAS hypertonia and to allow heal-
ing by improving anal blood flow. The reason why
topical treatment fails could be related to the absence
of IAS hypertonia. Further treatments, such as the
surgical sphincterotomy, designed to obtain a lower
resting pressure seem illogical; also the risk of fecal
incontinence is likely to be elevated as the sphincter is
already weakened.16 Chowcat et al. reported that some
patients with low sphincter pressure showed a further
decrease in time.17
The fissurectomy is the procedure most used to
preserve the anatomo-functional integrity of the anal
sphincters. Recently, Pelta et al.18 have described
a subcutaneous fissurotomy that involves de-roofing
a narrow subcutaneous tract found caudal to the fissure
and have reported a very high success rate and a low
incidence of repeated surgery.18 The fissurectomy has
been associated with lateral sphincterotomy and or
pharmacological19 treatment using drugs able to re-
duce the sphincters tone; however, the above pro-
cedures seem to be illogical in the treatment of CAF
without IAS hypertonia. Fissurectomy is the excision
of the anal fissure, and it can be associated with the
removal of the hypertrophied anal papilla and the skin
tags. Fissurectomy, as a wound debridement, removes
the bradytrophic scar tissue and creates fresh wound
edges, creating in essence an acute fissure. Only re-
cently, fissurectomy alone has been used to treat CAF
in adults with success;20, 21 however the possible
complication of keyhole defect that may lead to fecal
soiling limits its use.22
The use of skin graft to cover the defect in treating
CAF was first described in 1968.23 The rationale of
advancing flaps of skin and fat is based on introducing
a fresh blood supply to the ischemic area of the fis-
sure,24 reducing the time of perianal wound healing,
and avoiding the risk of anal stenosis that follows
healing by scarring.22 Nyam et al.25 reported in 21
patients the use of a broad based V-Yadvancement flap
to treat CAF with normal or low MRP; in their series,
all fissures healed with no flap necrosis or disturbance
of continence.25 Leong and Seow-Choen in their pro-
spective randomized trial compared the rhomboid ad-
vancement flap with the lateral sphincterotomy in 20
patients for each group.26 All fissures healed after
sphincterotomy, whereas three of the 20 failed healing
after treatment with advancement flap; among these,
two fissures were subsequently successfully treated by
sphincterotomy.26 Pescatori et al.27 observed that none
of the 13 patients, who underwent a fissurectomy with
anoplasty and who experienced no anal spasm at pre-
operative manometry, complained of incontinence or
recurrence after surgery.27 Singh et al.28 treated 21
patients affected by CAF resistant to topical treatment
with fissurectomy and rotational flap to reduce the
breakdown in the donor site. Seventeen patients had
complete resolution of symptoms, only one patient
continued to have severe pain, two developed a re-
current fissure, and one patient suffered from a break-
down of the flap and donor site.28 Kenefick et al.16
reported that eight patients affected by CAF that
resulted unresponsive to the surgical procedure with
normo or hypotonic IAS were treated successfully with
the advancement flap.16 Giordano et al., in their pro-
spective study of 51 consecutive patients with CAF,
irrespective of anal tone and patient’s gender, retains
that advancement flap anoplasty should be considered
as a first-line surgical treatment.29
TABLE 3. Data Collected from Different Studies About the Incidence of Normotonic or Hypotonic Internal Anal Sphincter in
Patients with CAF
Years N of Patients Normotonic IAS % Hypotonic IAS % Normotonic + Hypotonic %
Prohm and Bo¨nner10 1995 177 — — 24
Bove et al.11 2004 73 52 5 57
Jones et al.9 2005 40 55 8 63
Pascual et al.8 2007 124 — — 32
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In this study the fissurectomy and advancement flap
in patients without hypertonia of IAS has been effec-
tive in complete healing with full resolution of the
symptoms in all cases. The site for advancement was
determined by the position of the CAF. Although
wound infection and breakdown of the donor site are
known complications of this procedure, the infectious
complications and the breakdown of the donor site,
that we observed, has been of a very low entity and
never needed a reoperation. In conclusion, fissur-
ectomy and advancement flap for patients with CAF
without hypertonia of IAS represents a valid technique
to prevent the occurrence of incontinence. In this study,
only one case of temporary incontinence of low entity
has been observed, in addition the severity of in-
continence reported preoperatively by the patients did
not show signs of worsening.
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